Skip to main content
. 2016 Apr 29;7(24):36590–36601. doi: 10.18632/oncotarget.9096

Figure 5. Kaplan–Meier DFS and OS curves based on PD-L1 immunohistochemistry status and the distribution for the potential therapeutic targets detected in SqCLC.

Figure 5

A. Disease free survival (DFS) rates of SqCLC patients by PD-L1 expression status; B. Overall survival (OS) rates of SqCLC patients by PD-L1 expression status. C. The pie chart demonstrated the distribution for the potential therapeutic targets detected in SqCLC.